bioRxivMicrobiology
Defining Escherichia coli as a health-promoting microbe against intestinal Pseudomonas aeruginosa
T. Christofi, S. Panayidou, i. Dieronitou, C. Michael, Y. Apidianakis
Abstract
Gut microbiota acts as a barrier against intestinal pathogens, but species-specific protection of the host from infection remains relatively unexplored. Taking a Kochs postulates approach in reverse to define health-promoting microbes we find that Escherichia coli naturally colonizes the gut of healthy mice, but it is depleted from the gut of antibiotic-treated mice, which become susceptible to intestinal colonization by Pseudomonas aeruginosa and concomitant mortality. Reintroduction of fecal bacteria and E. coli establishes a high titer of E. coli in the host intestine and increases defence against P. aeruginosa colonization and mortality. Moreover, diet is relevant in this process because high sugars or dietary fat favours E. coli fermentation to lactic acid and P. aeruginosa growth inhibition. To the contrary, low sugars allow P. aeruginosa to produce the oxidative agent pyocyanin that inhibits E. coli growth. Our results provide an explanation as to why P. aeruginosa doesnt commonly infect the human gut, despite being a formidable microbe in lung and wound infections.\n\nAuthor SummaryHere we interrogate the conundrum as to why Pseudomonas aeruginosa is not a clinical problem in the intestine as opposed to other tissues. P. aeruginosa interacts with Neisseria, Streptococcus, Staphylococcus and Actinomyces species found in the human lung. These are predominantly gram-positive bacteria that induce P. aeruginosa virulence. Moreover, peptidoglycan, which is abundant in gram-positive bacteria, can directly trigger the virulence of P. aeriginosa. We reasoned that P. aeruginosa might be benign in the human gut due to the inhibitory action of benign gram-negative intestinal bacteria, such as Escherichia coli. Therefore, we dissected the antagonism between E. coli and P. aeruginosa and the effect of a conventional, a fat-, a carbohydrate-and a protein-based diet in intestinal dysbiosis. Our findings support the notion that an unbalanced diet or antibiotics induces gut dysbiosis by the elimination of commensal E. coli, in addition to lactic acid bacteria, imposing a gut environment conducive to P. aeruginosa infection. Moreover, commensal E. coli provides an explanation as to why P. aeruginosa doesnt commonly infect the human gut, despite being a formidable microbe in lung and wound infections.
- organism: mouse
- assay: metagenomics
- research focus: host-pathogen & immune response
- research focus: development & morphogenesis
- research focus: ecology & biodiversity
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Antibiotic resistance alters the ability of Pseudomonas aeruginosa to invade the respiratory microbiome
S. Lindon, S. Shah, … R. M. Wheatley·bioRxiv·Nov 14, 2023
- Competition against the intestinal microbiota selects for pathoadaptive traits in ESBL E. coli
Pramod Kumar Jangir, Leonardo F. Lemos Rocha, … Médéric Diard·bioRxiv·Jun 29, 2026
- Propionic acid promotes the virulent phenotype of Crohns disease-associated adherent-invasive Escherichia coli
M. J. Ormsby, S. A. Johnson, … D. M. Wall·bioRxiv·Dec 20, 2018
- Commensal bacteria can inhibit the growth of P. aeruginosa in cystic fibrosis airway infections through a released metabolite
A. Tony-Odigie, A. H. Dalpke, … B. Yi·bioRxiv·Feb 3, 2023
- Antibiotics promote intestinal growth of carbapenem-resistant Enterobacteriaceae by enriching nutrients and depleting microbial metabolites
A. Y. G. Yip, O. G. King, … J. A. K. McDonald·bioRxiv·Mar 25, 2023
- Roles of bacterial growth competition systems in colonization of the murine gut
Petra Muir, Jonas Kjellin, … Sanna Koskiniemi·bioRxiv·May 12, 2026